Wolverine Trading, LLC Summit Therapeutics Inc. Put Options Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$6.89 - $31.93 $978,380 - $4.53 Million
142,000 Added 1118.11%
154,700 $3.39 Million
Q2 2024

Aug 14, 2024
BUY
$2.39 - $10.92 $30,353 - $138,684
12,700 New
12,700 $99,000
Q1 2023

May 15, 2023
SELL
$1.38 - $5.41 $413 - $1,623
-300 Reduced 1.62%
18,200 $30,000
Q4 2022

Feb 14, 2023
BUY
$0.68 - $5.31 $12,580 - $98,235
18,500 New
18,500 $79,000

Others Institutions Holding SMMT

# of Institutions
193
Shares Held
75.8M
Call Options Held
2.01M
Put Options Held
2.84M
View Full List

About Summit Therapeutics Inc.

SMMT Quotes by TradingView
  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $3.82B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email